Quantcast

BIO-key(R) Biometric Identification Now Incorporated Into Evidian Enterprise Single Sign-On Solution

May 24, 2010

WALL, N.J., May 24 /PRNewswire-FirstCall/ — BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions, today announced that Evidian has integrated BIO-key’s biometric software into its Enterprise Single Sign-on (SSO) solution. Additionally Evidian has successfully deployed this biometric identification solution at two major pharmaceutical companies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO)

Evidian, A Bull Group Company, is the European leader and one of the major worldwide vendors of identity and access management (IAM) software. With Evidian’s Enterprise SSO equipped with BIO-key’s identification software, a user logs in once with the touch of a finger to establish identity. This single authentication method allows the user to gain access to his or her applications, eliminating the need to remember passwords or carry ID tokens which can be easily lost, forgotten or stolen.

Evidian has successfully installed this biometric identification solution at two global pharmaceutical companies who collectively have approximately 15,000 users of the BIO-key identification solution. “In addition to its exceptional speed and accuracy, one of the unique features BIO-key provides and that our customers demand is reader interoperability. Our customers have a variety of laptops, tablets and desktop computers with fingerprint readers from many different manufacturers. BIO-key’s ability to work with most major fingerprint readers indiscriminately is a great capability that we can now offer all our customers,” said Hassan Maad, Evidian Chief Operating Officer.

“We look forward to building on this relationship. Evidian’s Enterprise SSO solution is the fruit of over fifteen years experience in identity and access management,” said Mike DePasquale, BIO-keys president and CEO. “More than 2 million users worldwide access their applications every day with Evidian’s solution, and now with BIO-key’s biometric authentication software available, they have the option of a particularly convenient and secure way to log into their applications.”

BIO-key’s fingerprint biometrics offers Evidian SSO users a strong authentication alternative while reducing the operating costs associated with managing passwords and tokens. Users prefer replacing passwords with BIO-key biometric ID to avoid the headaches of remembering passwords. Gone are the days of the embarrassing phone calls to the help desk because of a forgotten password or lost token, which frequently seem to occur when an important deadline is fast approaching.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key’s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world’s largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key’s technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

About Evidian

Evidian has offices and partners throughout the world. Evidian software helps over 700 organizations in the world improve their agility, enhance security and comply with laws and regulations, while reducing costs. For more information about Evidian software, offices and partners, visit www.evidian.com

BIO-key Safe Harbor Statement

Certain statements contained in this press release may be construed as “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

SOURCE BIO-key International, Inc.


Source: newswire



comments powered by Disqus